Abstract
Multiple sclerosis (MS) is an autoimmune inflammatory demyelinating disease that affects the central nervous system (CNS), particularly, in young adults. Current MS treatments aim to reduce demyelination; however, these have limited efficacy, display side effects and lack of regenerative activities. Oligodendrocyte progenitor cells (OPCs) represents the major source for new myelin. Upon demyelination, OPCs get activated, proliferate, migrate towards the lesion, and differentiate into remyelinating oligodendrocytes. Although myelin repair (remyelination) represents a robust response to myelin damage, during MS, this regenerative phenomenon decays in efficiency or even fails. CNS-resident pericytes (CNS-PCs) are essential for vascular homeostasis regulating blood-brain barrier (BBB) permeability and stability as well as endothelial cells (ECs) function during angiogenesis and neovascularization. Recent studies indicate that CNS-PCs also play a crucial role regulating OPC function during remyelination, and very importantly, these cells are substantially affected in MS. This chapter summarizes important aspects of MS and CNS remyelination as well as it provides new insights supporting the contribution of CNS-PCs to myelin regeneration and to MS pathology. Currently, there is evidence arguing in favor of CNS-PCs as novel therapeutic targets for the development of future treatments for MS.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Abbreviations
- BBB:
-
Blood-brain barrier
- CC:
-
Corpus callosum
- CNS:
-
Central nervous system
- CNS-PCs:
-
Central nervous system-resident pericytes
- EAE:
-
Experimental autoimmune encephalomyelitis
- ECM:
-
Extracellular matrix
- ECs:
-
Endothelial cells
- FGF:
-
Fibroblast growth factor
- LPC:
-
Lysophosphatidylcholine
- MS:
-
Multiple sclerosis
- MSCs:
-
Mesenchymal stem cells
- MS-PP:
-
Multiple sclerosis primary progressive
- MS-RR:
-
Multiple sclerosis relapsing-remitting
- MS-SP:
-
Multiple sclerosis secondary progressive
- NSCs:
-
Neural stem cells
- NVU:
-
Neurovascular unit
- OB:
-
Olfactory bulb
- OPCs:
-
Oligodendroglial precursor/progenitor cells
- PDGFRalpha:
-
Platelet-derived growth factor receptor alpha
- PDGFRbeta:
-
Platelet-derived growth factor receptor beta
- PLCs:
-
Pericyte like cells
- RMS:
-
Rostral migratory stream
- SVZ:
-
Subventricular zone
References
Alonso, A., & Hernan, M. A. (2008). Temporal trends in the incidence of multiple sclerosis: A systematic review. Neurology, 71, 129–135.
Altman, J. (1969). Autoradiographic and histological studies of postnatal neurogenesis. IV. Cell proliferation and migration in the anterior forebrain, with special reference to persisting neurogenesis in the olfactory bulb. The Journal of Comparative Neurology, 137, 433–457.
Altman, J., & Das, G. (1965). Autoradiographic and histological evidence of postnatal hippocampal neurogenesis in rats. The Journal of Comparative Neurology, 124, 319–335.
Altman, J., & Das, G. D. (1964). Autoradiographic examination of the effects of enriched environment on the rate of glial multiplication in the adult rat brain. Nature, 204, 1161–1163.
Alvarez-Buylla, A., & Garcia-Verdugo, J. M. (2002). Neurogenesis in adult subventricular zone. The Journal of Neuroscience, 22, 629–634.
Armulik, A., Abramsson, A., & Betsholtz, C. (2005). Endothelial/pericyte interactions. Circulation Research, 97, 512–523.
Armulik, A., Genove, G., Mae, M., Nisancioglu, M. H., Wallgard, E., Niaudet, C., He, L., Norlin, J., Lindblom, P., Strittmatter, K., et al. (2010a). Pericytes regulate the blood-brain barrier. Nature, 468, 557–561.
Armulik, A., Genové, G., Mäe, M., Nisancioglu, M. H., Wallgard, E., Niaudet, C., He, L., Norlin, J., Lindblom, P., Strittmatter, K., et al. (2010b). Pericytes regulate the blood–brain barrier. Nature, 468, 557–561.
Arnett, H. A., Fancy, S. P., Alberta, J. A., Zhao, C., Plant, S. R., Kaing, S., Raine, C. S., Rowitch, D. H., Franklin, R. J., & Stiles, C. D. (2004). bHLH transcription factor Olig1 is required to repair demyelinated lesions in the CNS. Science, 306, 2111–2115.
Azevedo, P. O., Sena, I. F. G., Andreotti, J. P., Carvalho-Tavares, J., Alves, J. C., Cunha, T. M., Cunha, F. Q., Mintz, A., & Birbrair, A. (2018). Pericytes modulate myelination in the central nervous system. Journal of Cellular Physiology, 233, 5523–5529.
Bell, R. D., Winkler, E. A., Sagare, A. P., Singh, I., LaRue, B., Deane, R., & Zlokovic, B. V. (2010). Pericytes control key neurovascular functions and neuronal phenotype in the adult brain and during brain aging. Neuron, 68, 409–427.
Blakemore, W. F. (1972). Observations on oligodendrocyte degeneration, the resolution of status spongiosus and remyelination in cuprizone intoxication in mice. Journal of Neurocytology, 1, 413–426.
Blakemore, W. F. (1973). Demyelination of the superior cerebellar peduncle in the mouse induced by cuprizone. Journal of the Neurological Sciences, 20, 63–72.
Blakemore, W. F. (1974). Pattern of remyelination in the CNS. Nature, 249, 577–578.
Bondjers, C., He, L., Takemoto, M., Norlin, J., Asker, N., Hellstrom, M., Lindahl, P., & Betsholtz, C. (2006). Microarray analysis of blood microvessels from PDGF-B and PDGF-Rbeta mutant mice identifies novel markers for brain pericytes. The FASEB Journal, 20, 1703–1705.
Brahic, M. (2002). Theiler’s virus infection of the mouse, or: Of the importance of studying animal models. Virology, 301, 1–5.
Broman, T. (1964). Blood-brain barrier damage in multiple sclerosis, supravital test observations. Acta Neurologica Scandinavica, 40, 21–24.
Bruce, C. C., Zhao, C., & Franklin, R. J. (2010). Remyelination – An effective means of neuroprotection. Hormones and Behavior, 57, 56–62.
Carleton, A., Petreanu, L. T., Lansford, R., Alvarez-Buylla, A., & Lledo, P.-M. (2003). Becoming a new neuron in the adult olfactory bulb. Nature Neuroscience, 6, 507–518.
Compston, A., & Coles, A. (2008). Multiple sclerosis. Lancet, 372, 1502–1517.
Connick, P., Kolappan, M., Crawley, C., Webber, D. J., Patani, R., Michell, A. W., Du, M. Q., Luan, S. L., Altmann, D. R., Thompson, A. J., et al. (2012). Autologous mesenchymal stem cells for the treatment of secondary progressive multiple sclerosis: An open-label phase 2a proof-of-concept study. Lancet Neurology, 11, 150–156.
Crawford, A. H., Chambers, C., & Franklin, R. J. M. (2013). Remyelination: The true regeneration of the central nervous system. Journal of Comparative Pathology, 149, 242–254.
Crockett, D. P., Burshteyn, M., Garcia, C., Muggironi, M., & Casaccia-Bonnefil, P. (2005). Number of oligodendrocyte progenitors recruited to the lesioned spinal cord is modulated by the levels of the cell cycle regulatory protein p27Kip-1. Glia, 49, 301–308.
Dal Canto, M. C., & Rabinowitz, S. G. (1982). Experimental models of virus-induced demyelination of the central nervous system. Annals of Neurology, 11, 109–127.
Dawson, M. R., Levine, J. M., & Reynolds, R. (2000). NG2-expressing cells in the central nervous system: Are they oligodendroglial progenitors? Journal of Neuroscience Research, 61, 471–479.
De La Fuente, A. G., Lange, S., Silva, M. E., Gonzalez, G. A., Tempfer, H., van Wijngaarden, P., Zhao, C., Di Canio, L., Trost, A., Bieler, L., et al. (2017). Pericytes stimulate oligodendrocyte progenitor cell differentiation during CNS remyelination. Cell Reports, 20, 1755–1764.
Diaz-Flores, L., Gutierrez, R., Madrid, J. F., Varela, H., Valladares, F., Acosta, E., Martin-Vasallo, P., & Diaz-Flores, L. (2009). Pericytes. Morphofunction, interactions and pathology in a quiescent and activated mesenchymal cell niche. Histology and Histopathology, 24, 909–969.
Doetsch, F. (2003). A niche for adult neural stem cells. Current Opinion in Genetics & Development, 13, 543–550.
Doetsch, F., & Alvarez-Buylla, A. (1996). Network of tangential pathways for neuronal migration in adult mammalian brain. Proceedings of the National Academy of Sciences of the United States of America, 93, 14895–14900.
Doetsch, F., Caille, I., Lim, D. A., Garcia-Verdugo, J. M., & Alvarez-Buylla, A. (1999). Subventricular zone astrocytes are neural stem cells in the adult mammalian brain. Cell, 97, 703–716.
Doetsch, F., Garcia-Verdugo, J. M., & Alvarez-Buylla, A. (1997). Cellular composition and three-dimensional organization of the subventricular germinal zone in the adult mammalian brain. The Journal of Neuroscience, 17, 5046–5061.
Doetsch, F., & Scharff, C. (2001). Challenges for brain repair: Insights from adult neurogenesis in birds and mammals. Brain, Behavior and Evolution, 58, 306–322.
Dore-Duffy, P. (2008). Pericytes: Pluripotent cells of the blood brain barrier. Current Pharmaceutical Design, 14, 1581–1593.
Dore-Duffy, P., & Cleary, K. (2011). Morphology and properties of pericytes. Methods in Molecular Biology, 686, 49–68.
Ebers, G. C., & Sadovnick, A. D. (1993). The geographic distribution of multiple sclerosis: A review. Neuroepidemiology, 12, 1–5.
ElAli, A., Thériault, P., & Rivest, S. (2014). The role of pericytes in neurovascular unit remodeling in brain disorders. International Journal of Molecular Sciences, 15, 6453.
Esen, N., Serkin, Z., & Dore-Duffy, P. (2013). Induction of vascular remodeling: A novel therapeutic approach in EAE. Journal of the Neurological Sciences, 333, 88–92.
Fancy, S. P., Zhao, C., & Franklin, R. J. (2004). Increased expression of Nkx2.2 and Olig2 identifies reactive oligodendrocyte progenitor cells responding to demyelination in the adult CNS. Molecular and Cellular Neurosciences, 27, 247–254.
Ferguson, A. R., Hook, M. A., Garcia, G., Bresnahan, J. C., Beattie, M. S., & Grau, J. W. (2004). A simple post hoc transformation that improves the metric properties of the BBB scale for rats with moderate to severe spinal cord injury. Journal of Neurotrauma, 21, 1601–1613.
Ffrench-Constant, C., & Raff, M. C. (1986a). The oligodendrocyte-type-2 astrocyte cell lineage is specialized for myelination. Nature, 323, 335–338.
Ffrench-Constant, C., & Raff, M. C. (1986b). Proliferating bipotential glial progenitor cells in adult rat optic nerve. Nature, 319, 499–502.
Franklin, R. J., & Ffrench-Constant, C. (2008). Remyelination in the CNS: From biology to therapy. Nature Reviews. Neuroscience, 9, 839–855.
Franklin, R. J., & Hinks, G. L. (1999). Understanding CNS remyelination: Clues from developmental and regeneration biology. Journal of Neuroscience Research, 58, 207–213.
Franklin, R. J., & Kotter, M. R. (2008). The biology of CNS remyelination: The key to therapeutic advances. Journal of Neurology, 255(Suppl 1), 19–25.
Fünfschilling, U., Supplie, L. M., Mahad, D., Boretius, S., Saab, A. S., Edgar, J., Brinkmann, B. G., Kassmann, C. M., Tzvetanova, I. D., Möbius, W., et al. (2012). Glycolytic oligodendrocytes maintain myelin and long-term axonal integrity. Nature, 485, 517.
Gaceb, A., Özen, I., Padel, T., Barbariga, M., & Paul, G. (2017). Pericytes secrete pro-regenerative molecules in response to platelet-derived growth factor-BB. Journal of Cerebral Blood Flow & Metabolism, 38, 45–57.
Gage, F. H. (2000). Mammalian neural stem cells. Science, 287, 1433–1438.
Gensert, J. M., & Goldman, J. E. (1997). Endogenous progenitors remyelinate demyelinated axons in the adult CNS. Neuron, 19, 197–203.
Grygorowicz, T., Dąbrowska-Bouta, B., & Strużyńska, L. (2018). Administration of an antagonist of P2X7 receptor to EAE rats prevents a decrease of expression of claudin-5 in cerebral capillaries. Purinergic Signalling, 14(4), 385–393.
Gündüz, T., Tanyel Kiremitçi, T., Ulusoy, C., Kürtüncü, M., & Türkoğlu, R. (2018). Cerebrospinal fluid analysis of pericytic mediators in clinically isolated syndrome and multiple sclerosis: A preliminary study. Journal of Experimental Medicine, 81, 18–22.
Hellstrom, M., Gerhardt, H., Kalen, M., Li, X., Eriksson, U., Wolburg, H., & Betsholtz, C. (2001). Lack of pericytes leads to endothelial hyperplasia and abnormal vascular morphogenesis. The Journal of Cell Biology, 153, 543–553.
Hoftberger, R., & Lassmann, H. (2017). Inflammatory demyelinating diseases of the central nervous system. Handbook of Clinical Neurology, 145, 263–283.
Iacobaeus, E., Sugars, R. V., Andrén, A. T., Alm, J. J., Qian, H., Frantzen, J., Newcombe, J., Alkass, K., Druid, H., Bottai, M., Röyttä, M., Le Blanc, K. (2017). Dynamic Changes in Brain Mesenchymal Perivascular Cells Associate with Multiple Sclerosis Disease Duration, Active Inflammation, and Demyelination. Stem Cells Translational Medicine, 6(10),1840–1851.
Jablonska, B., Aguirre, A., Raymond, M., Szabo, G., Kitabatake, Y., Sailor, K. A., Ming, G. L., Song, H., & Gallo, V. (2010). Chordin-induced lineage plasticity of adult SVZ neuroblasts after demyelination. Nature Neuroscience, 13, 541–550.
Jadasz, J. J., Aigner, L., Rivera, F. J., & Kury, P. (2012). The remyelination Philosopher’s Stone: Stem and progenitor cell therapies for multiple sclerosis. Cell and Tissue Research, 349(1), 331–347.
Kabat, E. A., Wolf, A., Bezer, A. E., & Murray, J. P. (1951). Studies on acute disseminated encephalomyelitis produced experimentally in rhesus monkeys. The Journal of Experimental Medicine, 93, 615–633.
Kamouchi, M., Ago, T., & Kitazono, T. (2011). Brain pericytes: Emerging concepts and functional roles in brain homeostasis. Cellular and Molecular Neurobiology, 31, 175–193.
Keirstead, H. S., Levine, J. M., & Blakemore, W. F. (1998). Response of the oligodendrocyte progenitor cell population (defined by NG2 labelling) to demyelination of the adult spinal cord. Glia, 22, 161–170.
Kesterson, J. W., & Carlton, W. W. (1971). Histopathologic and enzyme histochemical observations of the cuprizone-induced brain edema. Experimental and Molecular Pathology, 15, 82–96.
Komoly, S., Jeyasingham, M. D., Pratt, O. E., & Lantos, P. L. (1987). Decrease in oligodendrocyte carbonic anhydrase activity preceding myelin degeneration in cuprizone induced demyelination. Journal of the Neurological Sciences, 79, 141–148.
Kornek, B., & Lassmann, H. (2003). Neuropathology of multiple sclerosis-new concepts. Brain Research Bulletin, 61, 321–326.
Krishnamoorthy, G., & Wekerle, H. (2009). EAE: An immunologist’s magic eye. European Journal of Immunology, 39, 2031–2035.
Krizbai, I. A., Bauer, H., Amberger, A., Hennig, B., Szabo, H., Fuchs, R., & Bauer, H. C. (2000). Growth factor-induced morphological, physiological and molecular characteristics in cerebral endothelial cells. European Journal of Cell Biology, 79, 594–600.
Kuchroo, V. K., Anderson, A. C., Waldner, H., Munder, M., Bettelli, E., & Nicholson, L. B. (2002). T cell response in experimental autoimmune encephalomyelitis (EAE): Role of self and cross-reactive antigens in shaping, tuning, and regulating the autopathogenic T cell repertoire. Annual Review of Immunology, 20, 101–123.
Lange, S., Trost, A., Tempfer, H., Bauer, H. C., Bauer, H., Rohde, E., Reitsamer, H. A., Franklin, R. J., Aigner, L., & Rivera, F. J. (2013). Brain pericyte plasticity as a potential drug target in CNS repair. Drug Discovery Today, 18, 456–463.
Larsen, P. H., Wells, J. E., Stallcup, W. B., Opdenakker, G., & Yong, V. W. (2003). Matrix metalloproteinase-9 facilitates remyelination in part by processing the inhibitory NG2 proteoglycan. The Journal of Neuroscience, 23, 11127–11135.
Lassmann, H. (2007a). Experimental models of multiple sclerosis. Revue Neurologique (Paris), 163, 651–655.
Lassmann, H. (2007b). Multiple sclerosis: Is there neurodegeneration independent from inflammation? Journal of the Neurological Sciences, 259, 3–6.
Lassmann, H., Bruck, W., Lucchinetti, C., & Rodriguez, M. (1997). Remyelination in multiple sclerosis. Multiple Sclerosis, 3, 133–136.
Lassmann, H., van Horssen, J., & Mahad, D. (2012). Progressive multiple sclerosis: Pathology and pathogenesis. Nature Reviews. Neurology, 8, 647–656.
Levine, J. M., & Reynolds, R. (1999). Activation and proliferation of endogenous oligodendrocyte precursor cells during ethidium bromide-induced demyelination. Experimental Neurology, 160, 333–347.
Levine, J. M., Reynolds, R., & Fawcett, J. W. (2001). The oligodendrocyte precursor cell in health and disease. Trends in Neurosciences, 24, 39–47.
Lindahl, P., Johansson, B. R., Leveen, P., & Betsholtz, C. (1997). Pericyte loss and microaneurysm formation in PDGF-B-deficient mice. Science, 277, 242–245.
Lois, C., Garcia-Verdugo, J. M., & Alvarez-Buylla, A. (1996). Chain migration of neuronal precursors. Science, 271, 978–981.
Lublin, F. D., & Reingold, S. C. (1996). Defining the clinical course of multiple sclerosis: Results of an international survey. National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis. Neurology, 46, 907–911.
Ludwin, S. K. (1978). Central nervous system demyelination and remyelination in the mouse: An ultrastructural study of cuprizone toxicity. Laboratory Investigation, 39, 597–612.
Ludwin, S. K., & Maitland, M. (1984). Long-term remyelination fails to reconstitute normal thickness of central myelin sheaths. Journal of the Neurological Sciences, 64, 193–198.
Maki, T., Maeda, M., Uemura, M., Lo, E. K., Terasaki, Y., Liang, A. C., Shindo, A., Choi, Y. K., Taguchi, A., Matsuyama, T., et al. (2015). Potential interactions between pericytes and oligodendrocyte precursor cells in perivascular regions of cerebral white matter. Neuroscience Letters, 597, 164–169.
Matsushima, G. K., & Morell, P. (2001). The neurotoxicant, cuprizone, as a model to study demyelination and remyelination in the central nervous system. Brain Pathology, 11, 107–116.
Menn, B., Garcia-Verdugo, J. M., Yaschine, C., Gonzalez-Perez, O., Rowitch, D., & Alvarez-Buylla, A. (2006). Origin of oligodendrocytes in the subventricular zone of the adult brain. The Journal of Neuroscience, 26, 7907–7918.
Montagne, A., Nikolakopoulou, A. M., Zhao, Z., Sagare, A. P., Si, G., Lazic, D., Barnes, S. R., Daianu, M., Ramanathan, A., Go, A., et al. (2018). Pericyte degeneration causes white matter dysfunction in the mouse central nervous system. Nature Medicine, 24, 326.
Murtie, J. C., Zhou, Y. X., Le, T. Q., Vana, A. C., & Armstrong, R. C. (2005). PDGF and FGF2 pathways regulate distinct oligodendrocyte lineage responses in experimental demyelination with spontaneous remyelination. Neurobiology of Disease, 19, 171–182.
Nait-Oumesmar, B., Decker, L., Lachapelle, F., Avellana-Adalid, V., Bachelin, C., & Van Evercooren, A. B. (1999). Progenitor cells of the adult mouse subventricular zone proliferate, migrate and differentiate into oligodendrocytes after demyelination. The European Journal of Neuroscience, 11, 4357–4366.
Noseworthy, J. H., Lucchinetti, C., Rodriguez, M., & Weinshenker, B. G. (2000). Multiple sclerosis. The New England Journal of Medicine, 343, 938–952.
Orton, S. M., Herrera, B. M., Yee, I. M., Valdar, W., Ramagopalan, S. V., Sadovnick, A. D., & Ebers, G. C. (2006). Sex ratio of multiple sclerosis in Canada: A longitudinal study. Lancet Neurology, 5, 932–936.
Peppiatt, C. M., Howarth, C., Mobbs, P., & Attwell, D. (2006). Bidirectional control of CNS capillary diameter by pericytes. Nature, 443, 700–704.
Quaegebeur, A., Segura, I., & Carmeliet, P. (2010). Pericytes: Blood-brain barrier safeguards against neurodegeneration? Neuron, 68, 321–323.
Raff, M. C., Miller, R. H., & Noble, M. (1983). A glial progenitor cell that develops in vitro into an astrocyte or an oligodendrocyte depending on culture medium. Nature, 303, 390–396.
Raff, M. C., Williams, B. P. A., & Miller, R. H. (1984). The in vitro differentiation of a bipotential glial progenitor cell. The EMBO Journal, 3, 1857–1864.
Ramagopalan, S. V., Dobson, R., Meier, U. C., & Giovannoni, G. (2010). Multiple sclerosis: Risk factors, prodromes, and potential causal pathways. Lancet Neurology, 9, 727–739.
Redwine, J. M., & Armstrong, R. C. (1998). In vivo proliferation of oligodendrocyte progenitors expressing PDGFalphaR during early remyelination. Journal of Neurobiology, 37, 413–428.
Reynolds, R., Dawson, M., Papadopoulos, D., Polito, A., Di Bello, I. C., Pham-Dinh, D., & Levine, J. (2002). The response of NG2-expressing oligodendrocyte progenitors to demyelination in MOG-EAE and MS. Journal of Neurocytology, 31, 523–536.
Ribatti, D., Nico, B., & Crivellato, E. (2011). The role of pericytes in angiogenesis. The International Journal of Developmental Biology, 55, 261–268.
Rinholm, J. E., Hamilton, N. B., Kessaris, N., Richardson, W. D., Bergersen, L. H., & Attwell, D. (2011). Regulation of oligodendrocyte development and myelination by glucose and lactate. The Journal of Neuroscience, 31, 538–548.
Rivera, F. J., & Aigner, L. (2012). Adult mesenchymal stem cell therapy for myelin repair in multiple sclerosis. Biological Research, 45, 257–268.
Rivera, F. J., Steffenhagen, C., Kremer, D., Kandasamy, M., Sandner, B., Couillard-Despres, S., Weidner, N., Kury, P., & Aigner, L. (2010). Deciphering the oligodendrogenic program of neural progenitors: Cell intrinsic and extrinsic regulators. Stem Cells and Development, 19, 595–606.
Rouget, C.-M. B. (1874). Note sur le developpement de la tunique contractile des vaisseaux. Comptes Rendus de l’Académie des Sciences, 59, 4.
Ruckh, J. M., Zhao, J.-W., Shadrach, J. L., van Wijngaarden, P., Rao, T. N., Wagers, A. J., & Franklin, R. J. M. (2012). Rejuvenation of regeneration in the aging central nervous system. Cell Stem Cell, 10, 96–103.
Scheikl, T., Pignolet, B., Mars, L. T., & Liblau, R. S. (2010). Transgenic mouse models of multiple sclerosis. Cellular and Molecular Life Sciences, 67, 4011–4034.
Schonrock, L. M., Kuhlmann, T., Adler, S., Bitsch, A., & Bruck, W. (1998). Identification of glial cell proliferation in early multiple sclerosis lesions. Neuropathology and Applied Neurobiology, 24, 320–330.
Shen, S., Sandoval, J., Swiss, V. A., Li, J., Dupree, J., Franklin, R. J., & Casaccia-Bonnefil, P. (2008). Age-dependent epigenetic control of differentiation inhibitors is critical for remyelination efficiency. Nature Neuroscience, 11, 1024–1034.
Shields, S. A., Gilson, J. M., Blakemore, W. F., & Franklin, R. J. (1999). Remyelination occurs as extensively but more slowly in old rats compared to young rats following gliotoxin-induced CNS demyelination. Glia, 28, 77–83.
Silva, M. E., Lange, S., Hinrichsen, B., Philp, A. R., Reyes, C. R., Halabi, D., Mansilla, J. B., Rotheneichner, P., De la Fuente, A. G., Couillard-Despres, S., Bátiz, L. F., Franklin, R. J. M., Aigner, L., Francisco, J., & Rivera, F. J. (2019). Pericytes favor oligodendrocyte fate choice in adult neural stem cells. Frontiers in Cellular Neuroscience, https://doi.org/10.3389/fncel.2019.00085.
Silvestroff, L., Bartucci, S., Soto, E., Gallo, V., Pasquini, J., & Franco, P. (2010). Cuprizone-induced demyelination in CNP::GFP transgenic mice. The Journal of Comparative Neurology, 518, 2261–2283.
Sim, F. J., Zhao, C., Penderis, J., & Franklin, R. J. (2002). The age-related decrease in CNS remyelination efficiency is attributable to an impairment of both oligodendrocyte progenitor recruitment and differentiation. The Journal of Neuroscience, 22, 2451–2459.
Skripuletz, T., Lindner, M., Kotsiari, A., Garde, N., Fokuhl, J., Linsmeier, F., Trebst, C., & Stangel, M. (2008). Cortical demyelination is prominent in the murine cuprizone model and is strain-dependent. The American Journal of Pathology, 172, 1053–1061.
Smith, K. J., McDonald, W. I., & Blakemore, W. F. (1979). Restoration of secure conduction by central demyelination. Transactions of the American Neurological Association, 104, 25–29.
Takakuni Maki, Y. K. C., Miyamoto, N., Shindo, A., Liang, A. C., Ahn, B. J. U., Mandeville, E. T., Kaji, S., Itoh, K., Seo, J. I. H., Gelman, I. H., Lok, J., Takahashi, R., Kim, K.-W., Lo, E. H., & Arai, K. (2018). A-kinase anchor protein 12 is required for oligodendrocyte differentiation in adult white matter. Stem Cells Translational Medicine, 36, 751–760.
Takata, F., Dohgu, S., Nishioku, T., Takahashi, H., Harada, E., Makino, I., Nakashima, M., Yamauchi, A., & Kataoka, Y. (2009). Adrenomedullin-induced relaxation of rat brain pericytes is related to the reduced phosphorylation of myosin light chain through the cAMP/PKA signaling pathway. Neuroscience Letters, 449, 71–75.
Tigges, U., Boroujerdi, A., Welser-Alves, J. V., & Milner, R. (2013). TNF-α promotes cerebral pericyte remodeling in vitro, via a switch from α1 to α2 integrins. Journal of Neuroinflammation, 10, 33–33.
Tintore, M., Vidal-Jordana, A., & Sastre-Garriga, J. (2019). Treatment of multiple sclerosis – success from bench to bedside. Nature Reviews Neurology, 15(1), 53–58.
Tsai, H.-H., Niu, J., Munji, R., Davalos, D., Chang, J., Zhang, H., Tien, A.-C., Kuo, C. J., Chan, J. R., Daneman, R., et al. (2016). Oligodendrocyte precursors migrate along vasculature in the developing nervous system. Science, 351, 379–384.
Vanlandewijck, M., He, L., Mae, M. A., Andrae, J., Ando, K., Del Gaudio, F., Nahar, K., Lebouvier, T., Lavina, B., Gouveia, L., et al. (2018). Author Correction: A molecular atlas of cell types and zonation in the brain vasculature. Nature, 560, E3.
Watanabe, M., Toyama, Y., & Nishiyama, A. (2002). Differentiation of proliferated NG2-positive glial progenitor cells in a remyelinating lesion. Journal of Neuroscience Research, 69, 826–836.
Whitacre, C. C. (2001). Sex differences in autoimmune disease. Nature Immunology, 2, 777–780.
Wilson, H. C., Scolding, N. J., & Raine, C. S. (2006). Co-expression of PDGF alpha receptor and NG2 by oligodendrocyte precursors in human CNS and multiple sclerosis lesions. Journal of Neuroimmunology, 176, 162–173.
Winkler, E. A., Bell, R. D., & Zlokovic, B. V. (2011). Central nervous system pericytes in health and disease. Nature Neuroscience, 14, 1398–1405.
Wolswijk, G., & Noble, M. (1989). Identification of an adult-specific glial progenitor cell. Development, 105, 387–400.
Woodruff, R. H., & Franklin, R. J. (1999). Demyelination and remyelination of the caudal cerebellar peduncle of adult rats following stereotaxic injections of lysolecithin, ethidium bromide, and complement/anti-galactocerebroside: A comparative study. Glia, 25, 216–228.
Woodruff, R. H., Fruttiger, M., Richardson, W. D., & Franklin, R. J. M. (2004). Platelet-derived growth factor regulates oligodendrocyte progenitor numbers in adult CNS and their response following CNS demyelination. Molecular and Cellular Neuroscience, 25, 252–262.
Yemisci, M., Gursoy-Ozdemir, Y., Vural, A., Can, A., Topalkara, K., & Dalkara, T. (2009). Pericyte contraction induced by oxidative-nitrative stress impairs capillary reflow despite successful opening of an occluded cerebral artery. Nature Medicine, 15, 1031–1037.
Zawadzka, M., Rivers, L. E., Fancy, S. P., Zhao, C., Tripathi, R., Jamen, F., Young, K., Goncharevich, A., Pohl, H., Rizzi, M., et al. (2010). CNS-resident glial progenitor/stem cells produce Schwann cells as well as oligodendrocytes during repair of CNS demyelination. Cell Stem Cell, 6, 578–590.
Zhang, S. C., Ge, B., & Duncan, I. D. (1999). Adult brain retains the potential to generate oligodendroglial progenitors with extensive myelination capacity. Proceedings of the National Academy of Sciences of the United States of America, 96, 4089–4094.
Zhou, Y. X., Flint, N. C., Murtie, J. C., Le, T. Q., & Armstrong, R. C. (2006). Retroviral lineage analysis of fibroblast growth factor receptor signaling in FGF2 inhibition of oligodendrocyte progenitor differentiation. Glia, 54, 578–590.
Zimmermann, K. W. (1923). Der feinere Bau der Blutkapillaren. Zeitschrift für Anatomie und Entwicklungsgeschichte, 68, 5.
Zlokovic, B. V. (2008). The blood-brain barrier in health and chronic neurodegenerative disorders. Neuron, 57, 178–201.
Acknowledgments
This work was supported by research funds from Chilean Comisión Nacional de Investigación CientÃfica y Tecnológica (CONICYT) FONDECYT Program Regular Grant Nº 1161787; Chilean CONICYT PCI Program Grant Nº REDES170233 and Grant Nº REDES180139; Chilean CONICYT FONDEF-IDeA Program Grant Nº ID17AM0043; Chilean CONICYT Doctoral Scholarship 21171884.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Rivera, F.J., Hinrichsen, B., Silva, M.E. (2019). Pericytes in Multiple Sclerosis. In: Birbrair, A. (eds) Pericyte Biology in Disease. Advances in Experimental Medicine and Biology, vol 1147. Springer, Cham. https://doi.org/10.1007/978-3-030-16908-4_8
Download citation
DOI: https://doi.org/10.1007/978-3-030-16908-4_8
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-16907-7
Online ISBN: 978-3-030-16908-4
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)